Dashboard
Manage Tickers

HTBXScorpius Holdings Inc.


$ 0.18 $ 0.00 (0.44 %)    

Friday, 10-May-2024 10:33:48 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 442.96 $ 0.90 (0.2 %)
DIA $ 394.52 $ -0.66 (-0.17 %)
SPY $ 520.61 $ -0.23 (-0.04 %)
TLT $ 90.36 $ 0.25 (0.28 %)
GLD $ 216.28 $ -2.43 (-1.11 %)
$ 0.176565
$ 0.18
$ 0.00 x 0
$ 0.00 x 0
$ 0.17 - $ 0.18
$ 0.15 - $ 0.89
154,555
na
na
$ 0.56
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

heat-biologics-nighthawk-biosciences-announces-that-its-elusys-therapeutics-subsidiary-has-executed-a-contract-to-deliver-anthim-to-the-canadian-government-for-c79m
Heat Biologics (nighthawk Biosciences) Ann...
04/27/2022 12:09:03

Heat Biologics, Inc. (NYSE American: HTBX) (to be renamed "NightHawk Biosciences"), a fully integrated biopharmaceutica...

heat-biologics-announces-planned-name-change-to-nighthawk-biosciences-will-trade-under-ticker-nhwk-effective-may-3-2022
Heat Biologics Announces Planned Name Chan...
04/19/2022 15:01:08

Heat Biologics, Inc. ("Heat") (NYSE American: HTBX), a clinical-stage biopharmaceutical company focused on developing n...

heat-biologics-subsidiary-outlines-development-of-new-commercialbiodefense-biomanufacturing-facility
Heat Biologics' Subsidiary Outlines Develo...
04/18/2022 14:29:28

heat-biologics-announces-planned-investor-and-media-livestream-event-to-discuss-latest-developments-for-april-19
Heat Biologics' Announces Planned Investor...
04/14/2022 16:37:38

Heat Biologics, Inc. ("Heat") (NYSE American: HTBX), a clinical-stage biopharmaceutical company focused on developing f...

heat-biologics-shares-spike-to-session-high-up-8-co-purchased-elusys-therapeutics-in-dec-2021-elusyss-anthim-was-approved-for-treatment-of-inhalation-of-anthrax-in-us-canada-europe-uk
Heat Biologics Shares Spike To Session Hig...
04/11/2022 19:57:56

https://ir.heatbio.com/press-releases/detail/706/heat-biologics-announces-planned-acquisition-of-elusys

Core News & Articles
Watching HIV Drug Manufacturers After Repo...
03/30/2022 15:18:48

heat-biologics-8-k-shows-co-elusys-therapeutics-waived-until-apr-30-2022-their-rights-to-terminate-deal-plan-of-merger-reorganization
Heat Biologics 8-K Shows Co., Elusys Thera...
03/24/2022 13:09:02

66-biggest-movers-from-yesterday
66 Biggest Movers From Yesterday
03/23/2022 08:25:32

Gainers JX Luxventure Limited (NASDAQ: LLL) shares jumped 119.5% to settle at $4.39 on Tuesday after the company announced i...

b-riley-securities-maintains-buy-on-heat-biologics-lowers-price-target-to-8
B. Riley Securities Maintains Buy on Heat ...
03/18/2022 14:25:37

B. Riley Securities analyst Mayank Mamtani maintains Heat Biologics (AMEX:HTBX) with a Buy and lowers the price target from ...

heat-biologics-shares-tick-higher-on-volume-following-circulation-of-zacks-small-cap-research-note-showing-19-valuation-target-on-stock
Heat Biologics Shares Tick Higher On Volum...
03/17/2022 15:02:09

https://s27.q4cdn.com/906368049/files/News/2022/Zacks_SCR_Reserach_03172022_HTBX_Vandermosten.pdf

heat-biologicss-return-on-capital-employed-overview
Heat Biologics's Return On Capital Employe...
03/15/2022 15:07:30

Heat Biologics (NASDAQ:HTBX) brought in sales totaling $613.10 thousand during Q4 according to data provided by Benzinga Pro. H...

stocks-that-hit-52-week-lows-on-tuesday
Stocks That Hit 52-Week Lows On Tuesday
03/08/2022 16:32:18

    Tuesday's session saw 729 companies set new 52-week lows.

heat-biologics-says-co-elusys-therapeutics-waived-until-march-31-their-right-to-terminate-agreement-and-plan-of-merger-and-reorganization
Heat Biologics Says Co, Elusys Therapeutic...
03/02/2022 21:44:43

-Reuters

heat-biologics-merger-partner-elusys-finalizes-hhs-contract-for-its-anthrax-treatment
Heat Biologics' Merger Partner Elusys Fina...
01/31/2022 14:59:24

Elusys Therapeutics Inc, the merger partner for Heat Biologics Inc (NASDAQ: HTBX), has 

heat-biologics-merger-partner-elusys-therapeutics-says-has-finalized-contract-with-hhs-office-of-the-assistant-secretary-for-preparedness-and-response-completed-first-phase-of-contract-for-50m
Heat Biologics Merger Partner Elusys Thera...
01/31/2022 12:37:00

Completed first phase of contract for $50 million; HHS options to procure up to $31 million of ANTHIM by the first half of 2023...

stocks-that-hit-52-week-lows-on-thursday
Stocks That Hit 52-Week Lows On Thursday
01/20/2022 15:37:55

  During Thursday's morning trading, 152 companies set new 52-week lows.

htbx-rapidvax-unveiled-elusys-acquisition
HTBX: RapidVax Unveiled; Elusys Acquisition
01/13/2022 19:43:00

By John Vandermosten, CFA NASDAQ:HTBX READ THE FULL HTBX RESEARCH REPORT

heat-biologics-shares-spiked-higher-midday-now-up-2-recent-zacks-small-cap-research-report-suggested-19-valuation-target-on-stock
Heat Biologics Shares Spiked Higher Midday...
01/13/2022 19:32:17

https://s27.q4cdn.com/906368049/files/News/2022/Zacks_SCR_Research_01132022_HTBX_Vandermosten.pdf

heat-biologics-issues-new-ptx-35-preclinical-data-in-organ-transplantation-update-on-hs-110
Heat Biologics Issues New PTX-35 Preclinic...
01/12/2022 16:27:08

Heat Biologics Inc (NASDAQ: HTBX) announced 

heat-biologics-announces-new-ptx-35-preclinical-data-in-organ-transplantation-and-provides-update-on-hs-110
Heat Biologics Announces New PTX-35 Precli...
01/12/2022 13:09:31

A single dose of the preclinical version of PTX-35 (mPTX-35), was able to expand regulatory T cells (Tregs) and significantly...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION